Related Experiment Video
Updated: May 13, 2026
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Anti-metastatic effect of cantharidin in A549 human lung cancer cells
Young Min Kim1, Min Jeong Ku, Young-Jin Son
1Department of Life Science, Gachon University, San 65, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Kyeonggi-Do, 461-701, Korea.
Abstract:
Cancer metastasis is represented by migration and invasion of cancer cells. Cancer cells invade into the blood or lymphatic vessels and this leads to the spread of cancer into the organs in distant sites. For cancer cells to migrate, extracellular matrix (ECM) must be degraded. Cantharidin, a compound derived from blister beetles, is known for its anti-cancer effect in several cancer cells. Here we report that cantharidin inhibits migration and invasion of A549 human lung cancer cell. We found that cantharidin inhibits activation of phosphatidylinositol 3-kinase/Akt signaling pathway. This leads to the selective attenuation of one of the gelatinases, matrix metalloproteinase 2, which can degrade components of ECM, and inhibits migration and invasion of A549 human lung cancer cell.
Insights
Cantharidin, a natural compound, effectively inhibits lung cancer cell migration and invasion by blocking key signaling pathways. This finding offers potential for new anti-cancer therapies targeting cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer metastasis involves cancer cell migration and invasion, crucial for distant spread.
- Extracellular matrix (ECM) degradation is essential for cancer cell migration.
- Cantharidin, derived from blister beetles, exhibits known anti-cancer properties.
Purpose of the Study:
- To investigate the effect of cantharidin on the migration and invasion of A549 human lung cancer cells.
- To elucidate the molecular mechanisms underlying cantharidin's anti-metastatic effects.
Main Methods:
- Cell culture of A549 human lung cancer cells.
- Assessment of cell migration and invasion assays.
- Analysis of the phosphatidylinositol 3-kinase/Akt signaling pathway.
- Quantification of matrix metalloproteinase 2 (MMP-2) activity.
Main Results:
- Cantharidin significantly inhibited the migration and invasion of A549 lung cancer cells.
- Cantharidin suppressed the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.
- Cantharidin selectively reduced the activity of matrix metalloproteinase 2 (MMP-2).
Conclusions:
- Cantharidin demonstrates potent anti-metastatic effects in A549 human lung cancer cells.
- The mechanism involves the inhibition of the PI3K/Akt pathway, leading to decreased MMP-2 activity.
- Cantharidin represents a potential therapeutic agent for inhibiting lung cancer metastasis.